We are live on ! Find out more
TARA icon

Protara Therapeutics
TARA

48 hedge funds and large institutions have $156M invested in Protara Therapeutics in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,500% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 1

45% more funds holding

Funds holding: 33 → 48 (+15)

36% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 11

33% more capital invested

Capital invested by funds: $118M → $156M (+$38.6M)

21.26% more ownership

Funds ownership: 67.81% → 89.06% (+21%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
48
Holders Change
+15
Holders Change %
+45.45%
% of All Funds
0.97%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
16
Increased
15
Reduced
11
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RSCM
Rock Springs Capital Management
Maryland
+$14.9M
2
PA
Perceptive Advisors
New York
+$14.1M
3
CAM
Cormorant Asset Management
Massachusetts
+$10.4M
4
O
OrbiMed
New York
+$10.4M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$10.4M

Top Sellers

Rank Fund Capital Flow
1
A
Abingworth
United Kingdom
-$765K
2
EP
Eversept Partners
New York
-$232K
3
HF
HRT Financial
New York
-$215K
4
Bank of America
Bank of America
North Carolina
-$40.8K
5
UBS Group
UBS Group
Switzerland
-$12.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
A
26
Abingworth
United Kingdom
$344K -$765K -33,002 -62%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$341K +$65.8K +2,838 +16%
Vanguard Group
28
Vanguard Group
Pennsylvania
$329K +$48.8K +2,103 +12%
Wells Fargo
29
Wells Fargo
California
$279K +$181K +7,800 +89%
MA
30
MYDA Advisors
New York
$236K +$325K +14,027 New
Two Sigma Investments
31
Two Sigma Investments
New York
$170K +$235K +10,119 New
DMK
32
David M. Knott
$134K +$95.4K +4,113 +107%
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$54K – – –
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$51K – – –
TRCT
35
Tower Research Capital (TRC)
New York
$31K +$40.3K +1,736 +1,887%
Bank of America
36
Bank of America
North Carolina
$30K -$40.8K -1,758 -50%
JP Morgan Chase
37
JP Morgan Chase
New York
$26K -$672 -29 -2%
AIG
38
American International Group
New York
$20K -$626 -27 -2%
Deutsche Bank
39
Deutsche Bank
Germany
$17K +$2.27K +98 +11%
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$13K +$3.64K +157 +26%
SO
41
STRS Ohio
Ohio
$8K – – –
Legal & General Group
42
Legal & General Group
United Kingdom
$5K -$603 -26 -8%
Morgan Stanley
43
Morgan Stanley
New York
$4K -$9.72K -419 -64%
AIP
44
Ameritas Investment Partners
Nebraska
$3K – – –
UBS Group
45
UBS Group
Switzerland
$2K -$12.3K -532 -79%
Citigroup
46
Citigroup
New York
$2K -$3.73K -161 -62%
Bank of Montreal
47
Bank of Montreal
Ontario, Canada
$2K -$1.76K -76 -45%
CIAS
48
CBIZ Investment Advisory Services
Ohio
$1K – – –
Millennium Management
49
Millennium Management
New York
$638 +$665K +28,698 +311%
HF
50
HRT Financial
New York
– -$215K -7,339 Closed
1
2

TARA Hedge Fund Activity: Q3 2020 in Review

48 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Protara Therapeutics (TARA) for Q3 2020, worth a combined $156M — up 33% from $118M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new TARA positions and 1 closed out — a net gain of 15 holders — while 15 added to existing stakes and 11 trimmed.

The largest buyer was Rock Springs Capital Management, opening a new position worth an estimated $14.9M. The largest seller was Abingworth, cutting an estimated $765K.

  • 48 institutional investors held Protara Therapeutics (TARA) as of Q3 2020, up from 33 in Q2 2020.
  • Funds reported $156M of Protara Therapeutics stock for Q3 2020, up 33% quarter-over-quarter.
  • 16 funds opened new Protara Therapeutics positions in Q3 2020 and 1 closed out, a net change of +15 holders.
  • The largest Protara Therapeutics buyer in Q3 2020 was Rock Springs Capital Management, an estimated $14.9M added.
  • The largest Protara Therapeutics seller in Q3 2020 was Abingworth, an estimated $765K sold.

Based on aggregated 13F filings for Q3 2020.